Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Coya Therapeutics (COYA) over the last 2 years, with Q3 2025 value amounting to $1.2 million.

  • Coya Therapeutics' Restructuring Costs rose 978.1% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2024, which is 227.6% down from last year.
  • Latest data reveals that Coya Therapeutics reported Restructuring Costs of $1.2 million as of Q3 2025, which was up 978.1% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Restructuring Costs registered a high of $1.5 million during Q2 2025, and its lowest value of $991941.0 during Q4 2024.